GMDA Gamida Cell Ltd. Stock Quote

GMDA [NASD]

Index	-	P/E	-	EPS (ttm)	-1.17	Insider Own	31.84%	Shs Outstand	49.47M	Perf Week	-11.32%
Market Cap	497.34M	Forward P/E	-	EPS next Y	-1.25	Insider Trans	0.00%	Shs Float	38.45M	Perf Month	-13.00%
Income	-55.10M	PEG	-	EPS next Q	-0.34	Inst Own	54.80%	Short Float	3.46%	Perf Quarter	22.24%
Sales	-	P/S	-	EPS this Y	51.90%	Inst Trans	61.40%	Short Ratio	1.00	Perf Half Y	98.56%
Book/sh	1.22	P/B	6.80	EPS next Y	5.30%	ROA	-65.30%	Target Price	-	Perf Year	85.68%
Cash/sh	1.22	P/C	6.78	EPS next 5Y	-	ROE	-112.80%	52W Range	2.60 - 15.00	Perf YTD	-1.07%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-44.67%	Beta	-
Dividend %	-	Quick Ratio	5.40	Sales past 5Y	-	Gross Margin	-	52W Low	219.23%	ATR	1.00
Employees	79	Current Ratio	5.40	Sales Q/Q	-	Oper. Margin	-	RSI (14)	39.58	Volatility	10.17% 10.07%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	23.40%	Profit Margin	-	Rel Volume	0.59	Prev Close	8.43
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Mar 09 BMO	Payout	-	Avg Volume	1.32M	Price	8.30
Recom	1.90	SMA20	-19.36%	SMA50	-11.74%	SMA200	32.40%	Volume	791,649	Change	-1.54%

Jul-01-20

Initiated

Evercore ISI

Outperform

May-26-20

Initiated

Piper Sandler

Overweight

$13

Apr-27-20

Initiated

H.C. Wainwright

Buy

$15

Nov-26-18

Initiated

Needham

Buy

$23

Nov-21-18

Initiated

Oppenheimer

Outperform

$15

Nov-20-18

Initiated

RBC Capital Mkts

Outperform

$20

Mar-03-21 07:00AM	Gamida Cell to Present at Upcoming Investor Conferences Business Wire
Mar-02-21 07:00AM	Gamida Cell Announces the Date of Its Full Year 2020 Financial Results and Webcast Business Wire
Mar-01-21 07:00AM	Gamida Cell Announces Results from Phase 3 Study of Omidubicel to be Presented at the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) Business Wire +5.02%
Feb-17-21 06:50AM	2 Top Biotech Stocks to Buy in February Motley Fool
Feb-16-21 07:00AM	Gamida Cell Announces $75 Million Financing with Highbridge Capital Management Business Wire -5.07%
Feb-14-21 03:02AM	Is Gamida Cell Ltd. (NASDAQ:GMDA) Popular Amongst Institutions? Simply Wall St.
Feb-10-21 02:44PM	Why Gamida Cell Stock Is Soaring Today Motley Fool +25.68%
07:34AM	The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs Benzinga
Feb-09-21 04:45PM	Gamida Cell Presents Efficacy and Safety Results of Phase 3 Study of Omidubicel in Patients with Hematologic Malignancies at the 2021 TCT Meetings of ASTCT and CIBMTR Business Wire
Feb-01-21 02:46AM	5 Low-Priced, Small-Cap Stocks Poised for Big Gains in 2021 TheStreet.com
Jan-11-21 03:00PM	Gamida Cell to Present Full Data from Phase 3 Study of Omidubicel at TCT, the Combined Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR Business Wire
Jan-05-21 04:01PM	Gamida Cell to Present at Upcoming January Investor Conferences Business Wire
Dec-21-20 04:30PM	Gamida Cell Announces Closing of $75 Million Public Offering, Including Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
Dec-18-20 08:00AM	Gamida Cell Added to NASDAQ Biotechnology Index Business Wire
Dec-17-20 09:43AM	Gamida Cell Announces Pricing of $65 Million Public Offering of Ordinary Shares Business Wire
Dec-16-20 09:03PM	Gamida Cell Announces Launch of Public Offering of Ordinary Shares Business Wire -7.14%
Dec-14-20 07:00AM	Gamida Cell Provides Regulatory Update on Biologics License Application for Omidubicel Business Wire -8.37%
Dec-10-20 08:17PM	Is GMDA A Good Stock To Buy Now? Insider Monkey +7.56%
08:21AM	Why Is Everyone Talking About Gamida Cell Stock? Motley Fool
Dec-09-20 07:00AM	Gamida Cell Provides Pipeline Update, Including Detailed Results of Pivotal Phase 3 Clinical Study of Omidubicel, and Prepares to Start BLA Submission by End of 2020 Business Wire -13.36%
Dec-07-20 03:33PM	Fate Stock Soars After Novel Natural-Killer Treatment for Cancers Makes a Splash Barrons.com +56.24%
Dec-05-20 10:30AM	Gamida Cell Presents Updated, Expanded Results from Phase 1 Study of Natural Killer Cell Therapy GDA-201 at ASH Annual Meeting and Exposition Business Wire
Dec-02-20 08:01AM	Gamida Cell to Host Virtual Pipeline Deep Dive Business Wire
Nov-24-20 08:01AM	Gamida Cell to Present at Upcoming Conferences Business Wire
Nov-16-20 04:17AM	We're Keeping An Eye On Gamida Cell's (NASDAQ:GMDA) Cash Burn Rate Simply Wall St.
Nov-10-20 08:01AM	Gamida Cell Reports Third Quarter 2020 Financial Results and Provides Company Update Business Wire
Nov-04-20 10:30AM	Gamida Cell Announces Data to Be Presented at 62nd ASH Annual Virtual Meeting Business Wire
08:01AM	Gamida Cell to Present at H.C. Wainwright 6th Annual Israel Conference Business Wire
Nov-02-20 08:01AM	Gamida Cell Announces the Date of Its Third Quarter 2020 Financial Results and Webcast Business Wire
Oct-13-20 08:01AM	Gamida Cell and Be The Match BioTherapies® Expand Strategic Collaboration Business Wire
Oct-09-20 08:32AM	Gamida Cell (GMDA) Jumps: Stock Rises 8.4% Zacks
Oct-07-20 10:14AM	Company News for Oct 7, 2020 Zacks
08:01AM	Gamida Cell to Present at 2020 Virtual Cell & Gene Meeting on the Mesa Business Wire
Oct-06-20 08:24AM	The Daily Biotech Pulse: Pfizer, BioNTech Begin European Filing For Coronavirus Vaccine, Y-mAbs BLA Rejected, GlycoMimetics Granted Rare Pediatric Disease Designation Benzinga +9.52%
06:31AM	Gamida Cell Announces Positive Topline Data on Secondary Endpoints from Phase 3 Clinical Study of Omidubicel in Patients with Hematologic Malignancies Business Wire
Sep-10-20 09:01AM	Gamida Cell Presents Analysis of Observational Data Demonstrating the Impact of Donor Age in Hematopoietic Stem Cell Transplant Outcomes at the Virtual Cord Blood Connect Meeting Business Wire
Sep-08-20 08:01AM	Gamida Cell to Participate in Upcoming Investor Conferences Business Wire
Sep-03-20 08:01AM	Gamida Cell Announces Two-Part Virtual Miniseries Focused on Omidubicel to Take Place in September Business Wire
Aug-18-20 03:29PM	What Type Of Shareholders Own The Most Number of Gamida Cell Ltd. (NASDAQ:GMDA) Shares? Simply Wall St.
Aug-17-20 08:00AM	Gamida Cell to Provide Webcast of Its Annual Meeting of Stockholders Business Wire +12.50%
Aug-11-20 08:42AM	Gamida Cell: Q2 Earnings Insights Benzinga
08:01AM	Gamida Cell Reports Second Quarter 2020 Financial Results and Provides Company Update Business Wire
Aug-04-20 08:31AM	Gamida Cell Announces the Date of Its Second Quarter 2020 Financial Results and Webcast Business Wire
Jul-23-20 11:09AM	Gamida Cell (GMDA) to Report Q2 Earnings: What's in Store? Zacks
Jul-21-20 08:01AM	Gamida Cell Announces Appointment of Michele Korfin as Chief Operating and Chief Commercial Officer Business Wire
Jul-20-20 11:30AM	Has Gamida Cell (GMDA) Outpaced Other Medical Stocks This Year? Zacks
Jul-07-20 08:30AM	Gamida Cell Announces Appointment of David Fox to Its Board of Directors Business Wire
Jun-25-20 08:58AM	Ovid Therapeutics (OVID) Jumps: Stock Rises 12.4% Zacks
Jun-19-20 12:00PM	Gamida Cell (GMDA) Upgraded to Strong Buy: Here's Why Zacks +5.46%
Jun-12-20 08:31AM	Gamida Cell to Present at the JMP Securities Virtual Hematology and Oncology Forum Business Wire
Jun-10-20 04:34PM	Gamida Cell Ltd. (GMDA): Hedge Funds In Wait-and-See Mode Insider Monkey
May-28-20 10:54AM	Top Ranked Momentum Stocks to Buy for May 28th Zacks
May-26-20 09:01AM	Gamida Cell Announces Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire +8.11%
08:50AM	Gamida Cell (GMDA): Strong Industry, Solid Earnings Estimate Revisions Zacks
May-22-20 10:58AM	Top Ranked Momentum Stocks to Buy for May 22nd Zacks +8.38%
May-21-20 09:22AM	3 Strong Buy Biotech Stocks Under $5 With Massive Upside Potential TipRanks +10.63%
08:01AM	Gamida Cell Reports First Quarter 2020 Financial Results and Provides Company Update Business Wire
May-19-20 06:53PM	8 Biotechs Tapping Secondary Markets for $3 Billion GuruFocus.com -26.27%
May-18-20 10:40PM	Gamida Cell Announces Pricing of $60 Million Public Offering of Ordinary Shares Business Wire -6.94%
04:01PM	Gamida Cell Announces Launch of Proposed Public Offering of Ordinary Shares Business Wire
May-17-20 09:02AM	Here's Why We're Watching Gamida Cell's (NASDAQ:GMDA) Cash Burn Situation Simply Wall St.
May-13-20 10:12AM	Company News for May 13, 2020 Zacks
May-12-20 05:00AM	Gamida Cell Announces Positive Topline Data from Phase 3 Clinical Study of Omidubicel in Patients with High-Risk Hematologic Malignancies Business Wire +36.56%
Mar-02-20 09:23AM	New Strong Sell Stocks for March 2nd Zacks +8.55%
08:01AM	Gamida Cell Announces Updated Data from Phase 1 Study of GDA-201 to be Presented at the Annual Meeting of the European Society for Blood and Marrow Transplantation Business Wire
Feb-25-20 07:31AM	Gamida Cell Reports Full Year 2019 Financial Results and Provides Company Update Business Wire -7.45%
06:30AM	Gamida Cell Ltd. to Host Earnings Call ACCESSWIRE
Feb-19-20 08:01AM	Gamida Cell Announces the Date of Its Full Year 2019 Financial Results and Webcast Business Wire
Jan-13-20 08:01AM	Gamida Cell Announces 2020 Goals and Provides Company Update Business Wire -6.53%
Jan-02-20 08:01AM	Gamida Cell Announces Completion of Patient Enrollment in Ongoing Phase 3 Clinical Study of Omidubicel Business Wire
Dec-20-19 10:18AM	Is Gamida Cell Ltd. (GMDA) A Good Stock To Buy? Insider Monkey
Dec-10-19 07:56AM	The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares Benzinga -7.37%
Dec-09-19 02:45PM	Gamida Cell Announces Results from Phase 1 Study of GDA-201 and New Mechanism of Action Data at ASH 2019 Annual Meeting Business Wire -6.86%
Nov-21-19 08:01AM	Gamida Cell to Present at the 31st Annual Piper Jaffray Healthcare Conference Business Wire
Nov-19-19 10:54AM	Will Gamida Cell (NASDAQ:GMDA) Spend Its Cash Wisely? Simply Wall St.
Nov-13-19 04:01PM	Gamida Cell Reports Third Quarter 2019 Financial Results and Provides Company Update Business Wire
Nov-06-19 09:01AM	Gamida Cell Announces Data to be Presented at ASH 2019 Annual Meeting Business Wire
Nov-05-19 08:31AM	Gamida Cell Announces the Date of Its Third Quarter 2019 Financial Results and Webcast Business Wire
Oct-11-19 06:32PM	3 Strong Buy Biotech Stocks That Could Triple in 2020 TipRanks
Sep-11-19 08:00AM	Gamida Cell and the CIBMTR Announce Collaboration to Advance Research for Life-Saving Cellular Therapy Business Wire
Aug-21-19 03:39PM	Could Gamida Cell Ltd.'s (NASDAQ:GMDA) Investor Composition Influence The Stock Price? Simply Wall St.
Aug-19-19 08:12AM	Gamida Cell Enters Oversold Territory Zacks
Aug-06-19 08:00AM	Gamida Cell Reports Second Quarter 2019 Financial Results and Provides Company Update Business Wire
Jul-23-19 08:01AM	Gamida Cell Announces the Date of Its Second Quarter 2019 Financial Results and Webcast Business Wire -5.56%
Jul-08-19 11:45AM	Gamida Cell Announces Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
Jun-26-19 09:30PM	Gamida Cell Announces Pricing of $35 Million Public Offering of Ordinary Shares Business Wire
Jun-25-19 08:30AM	ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL ANNOUNCES LAUNCH OF PROPOSED PUBLIC OFFERING OF ORDINARY SHARES GlobeNewswire -30.83%
Jun-24-19 04:12PM	Gamida Cell Announces Launch of Proposed Public Offering of Ordinary Shares Business Wire
Jun-19-19 01:00AM	Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel Business Wire
Jun-05-19 08:35AM	Gamida Cell Bolsters Management Team with Appointment of Tracey Lodie, Ph.D., as Chief Scientific Officer Business Wire
May-31-19 08:31AM	Gamida Cell Announces Data for Omidubicel Presented at the International Society for Cellular and Gene Therapy 2019 Annual Meeting Business Wire
May-29-19 08:31AM	Gamida Cell to Hold Annual Meeting of Stockholders Business Wire
May-09-19 08:31AM	Gamida Cell to Participate in Two Upcoming Healthcare Conferences in New York City Business Wire
May-07-19 04:23PM	Gamida Cell: 1Q Earnings Snapshot Associated Press
07:31AM	Gamida Cell Reports First Quarter 2019 Financial Results and Provides Company Update Business Wire
Apr-30-19 08:31AM	Gamida Cell Announces the Date of Its First Quarter 2019 Financial Results and Webcast Business Wire -8.82%
Apr-22-19 08:31AM	Gamida Cell to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor Day Business Wire
Apr-05-19 08:01AM	Gamida Cell to Present at the 18th Annual Needham Healthcare Conference Business Wire
Mar-21-19 08:29AM	Gamida Cell Nominates Two Healthcare Industry Veterans to Its Board of Directors Business Wire
Mar-19-19 09:13AM	Gamida Cell Sees Hammer Chart Pattern: Time to Buy? Zacks

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a nicotinamide expanded hematopoietic stem cells and differentiated immune cells, including T cells that is in Phase 3 studies in patients with high-risk hematologic malignancies, as well as in Phase 1/2 clinical trial in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase 1/2 studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was founded in 1998 and is headquartered in Jerusalem, Israel.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience